Future Directions of Proton Beam Radiotherapy for Bone and Soft Tissue Tumors
Bone and soft tissue tumors frequently recur locally when treated with surgery alone. Therefore, in an effort to improve treatment outcome, combined surgery and radiotherapy has been advocated as an effective modality. However, with conventional radiation, these tumors can usually be given only a moderate dose of radiation with the result that most recur locally. In this regard, proton beam radiotherapy offers potential advantages with respect to dose distribution characterized by Bragg-peak formation, which allows precise delivery of high radiation doses to a tumor while avoiding irradiation to adjacent normal tissues [1, 2].
KeywordsSoft Tissue Sarcoma Proton Beam Soft Tissue Tumor Local Control Rate Proton Therapy
Unable to display preview. Download preview PDF.
- 1.Munzenrider JE (1987) Clinical results of proton beam radiotherapy in Boston. In: Proc of 8th ICRR (vol 2 ). Taylor and Francis, New York, pp 916–922Google Scholar
- 4.Suit HD (1982) Soft tissue sarcomas: The role of radiation therapy. Hospital Practice, July, pp 114–120Google Scholar
- 11.Austin-Seymour M, Urie M, Munzenrider JE, Willett C (1989) Consideration in fractionated proton radiation therapy: Clinical potential and results. Radiother Oncol 70: 13–17Google Scholar
- 13.Linstadt D, Castro JR, Phillips TL (to be published) Neon ion radiotherapy: Results of the phase I—II clinical trials. Int J Radiat Oncol Biol PhysGoogle Scholar
- 14.Tsujii H (1989) Clinical results of high energy proton radiotherapy at Tsukuba. In: Proc of Int Heavy Particle Therapy Workshop, pp 90–94Google Scholar